circASXL1-1 regulates BAP1 deubiquitinase activity in leukemia

Shweta Pradip Jadhav; Nishi Kumari; Larry Ng; Pei Fang Tan; Nicole Shu Ling Yeo-Teh; Yufen Goh; Wee Nih Fam; Jia Qi Tng; Johann Shane Tian; Bryan T.H. Koh; Chan Ming Chun; Wilson Wang; Wee Joo Chng; Melissa Jane Fullwood; Ernesto Guccione; Neerja Karnani; Daniel G. Tenen; Sudhakar Jha

doi:10.3324/haematol.2019.225961

circASXL1-1 regulates BAP1 deubiquitinase activity in leukemia

Shweta Pradip Jadhav
, Nishi Kumari
, Larry Ng
, Pei Fang Tan
, Nicole Shu Ling Yeo-Teh
, Yufen Goh
, Wee Nih Fam
, Jia Qi Tng
, Johann Shane Tian
, Bryan T.H. Koh
, Chan Ming Chun
, Wilson Wang
, Wee Joo Chng
, Melissa Jane Fullwood
, Ernesto Guccione
, Neerja Karnani
, Daniel G. Tenen
, Sudhakar Jha

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	E343E348
Journal	Haematologica
Volume	105
Issue number	7
DOIs	https://doi.org/10.3324/haematol.2019.225961
State	Published - 1 Jul 2020

Access to Document

10.3324/haematol.2019.225961

Cite this

Jadhav, S. P., Kumari, N., Ng, L., Tan, P. F., Ling Yeo-Teh, N. S., Goh, Y., Fam, W. N., Tng, J. Q., Tian, J. S., Koh, B. T. H., Chun, C. M., Wang, W., Chng, W. J., Fullwood, M. J., Guccione, E., Karnani, N., Tenen, D. G., & Jha, S. (2020). circASXL1-1 regulates BAP1 deubiquitinase activity in leukemia. Haematologica, 105(7), E343E348. https://doi.org/10.3324/haematol.2019.225961

@article{2fb617237c524b49a3d555154a29162e,

title = "circASXL1-1 regulates BAP1 deubiquitinase activity in leukemia",

author = "Jadhav, \{Shweta Pradip\} and Nishi Kumari and Larry Ng and Tan, \{Pei Fang\} and \{Ling Yeo-Teh\}, \{Nicole Shu\} and Yufen Goh and Fam, \{Wee Nih\} and Tng, \{Jia Qi\} and Tian, \{Johann Shane\} and Koh, \{Bryan T.H.\} and Chun, \{Chan Ming\} and Wilson Wang and Chng, \{Wee Joo\} and Fullwood, \{Melissa Jane\} and Ernesto Guccione and Neerja Karnani and Tenen, \{Daniel G.\} and Sudhakar Jha",

note = "Funding Information: 1Cancer Science Institute of Singapore, National University of Singapore, Singapore; 2Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; 3Singapore Institute for Clinical Sciences, A*STAR, Singapore; 4National University of Singapore Graduate School for Integrative Sciences and Engineering, Singapore; 5Department of Orthopedic Surgery, National University Health Systems, Singapore; 6Department of Orthopedic Surgery, National University of Singapore, Singapore; 7Department of Hematology-Oncology, National University Cancer Institute, Singapore; 8School of Biological Sciences, Nanyang Technological Institute, Singapore; 9Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore; 10Tisch Cancer Institute, Department of Oncological Sciences and Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA and 11Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA Acknowledgments: we thank the staff of Jha{\textquoteright}s laboratory for helpful discussion and comments. Funding: SJ (R-713-006-014-271 and R-713-103-006-135), DGT, WJC, and MJF were supported by grants from the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiative to the Cancer Science Institute of Singapore. SJ, DGT, EG, WJC, and MJF were supported by the RNA Biology Center at Cancer Science Institute of Singapore, National University of Singapore, with funding from the Singapore Ministry of Education{\textquoteright}s AcRF Tier 3 grants (MOE2014-T3-1-006). DGT was supported by the Singapore Ministry of Health's National Medical Research Council through a Singapore Translational Research (STaR) Investigator Award and by National Institutes of Health/National Cancer Institute grant R35CA197697. Correspondence: SUDHAKAR JHA - [email protected] doi:10.3324/haematol.2019.225961 Information on authorship, contributions, and financial \& other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",

year = "2020",

month = jul,

day = "1",

doi = "10.3324/haematol.2019.225961",

language = "English",

volume = "105",

pages = "E343E348",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "7",

}

TY - JOUR

T1 - circASXL1-1 regulates BAP1 deubiquitinase activity in leukemia

AU - Jadhav, Shweta Pradip

AU - Kumari, Nishi

AU - Ng, Larry

AU - Tan, Pei Fang

AU - Ling Yeo-Teh, Nicole Shu

AU - Goh, Yufen

AU - Fam, Wee Nih

AU - Tng, Jia Qi

AU - Tian, Johann Shane

AU - Koh, Bryan T.H.

AU - Chun, Chan Ming

AU - Wang, Wilson

AU - Chng, Wee Joo

AU - Fullwood, Melissa Jane

AU - Guccione, Ernesto

AU - Karnani, Neerja

AU - Tenen, Daniel G.

AU - Jha, Sudhakar

N1 - Funding Information: 1Cancer Science Institute of Singapore, National University of Singapore, Singapore; 2Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; 3Singapore Institute for Clinical Sciences, A*STAR, Singapore; 4National University of Singapore Graduate School for Integrative Sciences and Engineering, Singapore; 5Department of Orthopedic Surgery, National University Health Systems, Singapore; 6Department of Orthopedic Surgery, National University of Singapore, Singapore; 7Department of Hematology-Oncology, National University Cancer Institute, Singapore; 8School of Biological Sciences, Nanyang Technological Institute, Singapore; 9Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore; 10Tisch Cancer Institute, Department of Oncological Sciences and Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA and 11Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA Acknowledgments: we thank the staff of Jha’s laboratory for helpful discussion and comments. Funding: SJ (R-713-006-014-271 and R-713-103-006-135), DGT, WJC, and MJF were supported by grants from the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiative to the Cancer Science Institute of Singapore. SJ, DGT, EG, WJC, and MJF were supported by the RNA Biology Center at Cancer Science Institute of Singapore, National University of Singapore, with funding from the Singapore Ministry of Education’s AcRF Tier 3 grants (MOE2014-T3-1-006). DGT was supported by the Singapore Ministry of Health's National Medical Research Council through a Singapore Translational Research (STaR) Investigator Award and by National Institutes of Health/National Cancer Institute grant R35CA197697. Correspondence: SUDHAKAR JHA - [email protected] doi:10.3324/haematol.2019.225961 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2020/7/1

Y1 - 2020/7/1

UR - https://www.scopus.com/pages/publications/85087469942

U2 - 10.3324/haematol.2019.225961

DO - 10.3324/haematol.2019.225961

M3 - Letter

C2 - 31780633

AN - SCOPUS:85087469942

SN - 0390-6078

VL - 105

SP - E343E348

JO - Haematologica

JF - Haematologica

IS - 7

ER -